Shenzhen Weiguang Biological Products Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 735.43 million compared to CNY 411.43 million a year ago. Revenue was CNY 735.43 million compared to CNY 411.43 million a year ago.

Net income was CNY 151.24 million compared to CNY 72.77 million a year ago. Basic earnings per share from continuing operations was CNY 0.6668 compared to CNY 0.3209 a year ago. Diluted earnings per share from continuing operations was CNY 0.6668 compared to CNY 0.3209 a year ago.